India  

AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

DNA Wednesday, 1 May 2024
In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their...

You Might Like


Related videos from verified sources

UTAH MOM SUES ASTRAZENECA IN MAJOR COVID VACCINE INJURY LAWSUIT [Video]

UTAH MOM SUES ASTRAZENECA IN MAJOR COVID VACCINE INJURY LAWSUIT

The HighWire with Del Bigtree - UTAH MOM SUES ASTRAZENECA IN MAJOR COVID VACCINE INJURY LAWSUIT

Credit: Rumble     Duration: 24:18Published
Deep State Hates This Technology [Video]

Deep State Hates This Technology

Deep State has an agenda to drastically reduce the population of this planet. The cash-cow medical system and Big Pharma are their Tools. They want to keep us sick and shorten our lives. They want..

Credit: Rumble     Duration: 01:18Published
AstraZeneca Vaccine Pulled From The Global Market [Video]

AstraZeneca Vaccine Pulled From The Global Market

Say goodbye to AstraZeneca in the global vaccine market as we uncover the shocking reasons for its withdrawal. From its controversial side effects to the impact on COVID-19 vaccination efforts, this is..

Credit: Rumble     Duration: 04:26Published

Related news from verified sources

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS),...
IndiaTimes